![]() |
Custom Search
|
Zoledronic acid stabilized mineral density in premenopausal women, study finds THURSDAY, Aug. 21 (HealthDay News) -- Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal women undergoing chemotherapy after they had surgery ... Read the entire article at National Library of Medicine | ||||
|